If you experience any unexpected symptoms after administration including nausea, vomiting, injection site swelling or redness, signs of allergic reaction (rash, difficulty breathing, swelling of the face or throat), or systemic symptoms such as fever you should: Contact your GP promptly for non-urgent concerns Call NHS 111 if you are unsure whether your symptoms require urgent attention Call 999 or attend A&E immediately if you experience a severe allergic reaction, chest pain, difficulty breathing, or loss of consciousness Suspected side effects or adverse reactions to any medicine, including investigational products, should be reported to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk
Enhanced endosomal signaling and desensitization of GLP-1R vs GIPR in pancreatic beta cells
Many of these barrier-impairing mechanisms are dependent on their ability to secrete the toxins responsible for the intestinal pathologies associated with infection
3 Cardiac arrhythmias affected 2-11% of participants on retatrutide versus 2% on placebo, but none were serious
Genetic insights can help your provider personalize your treatment plan, choose between injection and oral formats, or adjust dosing strategy to improve adherence and outcomes
